Potential for Abuse of Hydrocodone Combination Products

Published Online: Monday, January 13, 2014
Follow Pharmacy_Times:
In this video, Mary Lynn McPherson, PharmD, professor and vice chair at the University of Maryland School of Pharmacy, discusses the appeal of hydrocodone combination products to drug abusers.
 
This is the third in a series of videos in which Dr. McPherson argues in favor of categorizing hydrocodone combination products as Schedule II drugs, and Jeff Fudin, PharmD, argues against doing so. (Drs. McPherson and Fudin were assigned to take these positions for a session at the American Society of Health-System Pharmacists 2013 Midyear Clinical Meeting in Orlando, and their arguments do not necessarily reflect their personal positions on the issue.)
 
These videos were filmed at the ASHP 2013 Midyear Clinical Meeting in Orlando.

Related Articles
This year's pharmacy residency matches have been released, stirring up emotions ranging from sheer satisfaction to dread and panic.
Tighter hydrocodone regulations meant to reduce opioid abuse are hindering pain patients’ access to the products.
AWARxE is a free resource created by the National Association of Boards of Pharmacy to raise awareness on the dangers of prescription drug abuse.
Ludy L. Underwood, Cardinal Health sales manager for retail/alternative care, pharmaceutical division, talks about new programs Cardinal Health has introduced in response to industry changes.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$